Ken Griffin acquired 67.9 Thousand Twist Bioscience shares worth $1.1 Million. That's 0.00% of their equity portfolio (3172nd largest holding). The first Twist Bioscience trade was made in Q3 2019. Since then Ken Griffin bought shares seven more times and sold shares on four occasions. The investor's estimated purchase price is $4.14 Million, resulting in a loss of 73%.